Neuropharmacology of New Psychoactive Substances (NPS)

  title={Neuropharmacology of New Psychoactive Substances (NPS)},
  author={Michael H Baumann and Richard A Glennon and Jenny L. Wiley},
  booktitle={Current Topics in Behavioral Neurosciences},
The term “new psychoactive substances” (NPS) can be defined as individual drugs in pure form or in complex preparations that are not scheduled under the Single Convention on Narcotic Drugs (1961) or the Convention on Psychotropic Substances (1971). NPS may be categorized by chemical structure, by psychoactive properties, by biological targets, or by source (plant, synthetic, or combined). The emergence of hundreds of NPS in the past decade is challenging for public health and drug policies… 
Metabolomics predicts the pharmacological profile of new psychoactive substances
A metabolomics-targeted approach to predict the pharmacological profile of NPS that allows a fast NPS pharmacological classification which will benefit both drug risk evaluation policies and public health.
Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications
The molecular mechanisms of synthetic opioids, synthetic cannabinoids, stimulants, psychedelics, and hallucinogens were reviewed and mostly involved both a receptor-mediated and non-receptor mediated cellular modulation with multiple neurotransmitters interactions.
Molecular toxicological mechanisms of new psychoactive substances "in vitro"
Para-halogenation of amphetamines and cathinones increase the risk for serotonergic neurotoxicity, which may induce hyperthermia in vivo, and results indicated mitochondrial dysfunction associated with these drugs.
The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review
This work provides a review on existing literature about the development of synthetic cannabinoids as substances of abuse, current patterns of abuse and their legal status, chemical classification, and some pharmacological and toxicological properties.
Self-Experiments with Psychoactive Substances: A Historical Perspective.
The purpose of this chapter is to highlight the rich tradition of self-experiments (SEs) with psychoactive substances carried out by scientists and therapists for more than a century. Scientifically
The e-Psychonauts’ ‘Spiced’ World; Assessment of the Synthetic 
Cannabinoids’ Information Available Online
Assessing psychonauts’ fora/platforms to better understand the online mentions of SC and strengthening multidisciplinary collaboration between clinicians and bioinformatics may prove useful in better assessing SC-associated public health risks.
Mechanisms and Methods for Placing New Psychoactive Substances under Control
The article deals with the international and national mechanisms used to place new psychoactive substances under control. The authors provide an overview of the systems in use in the United Nations
Novel Psychoactive Substances and Trends of Abuse
The most common and quickest growing classes of novel, or new, psychoactive substances are reviewed to facilitate a better understanding of the toxicity associated with them and allow for successful identification of and management in the critical care unit.


Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review
Designer psychostimulants: Pharmacology and differences
The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample
The NBOMe drugs have emerged recently, are frequently bought using the internet and have similar effects to other hallucinogenic drugs; however, they may pose larger risks, due to the limited knowledge about them, their relatively low price and availability via the internet.
The Reinforcing and Rewarding Effects of Methylone, a Synthetic Cathinone Commonly Found in "Bath Salts"
Results reveal that methylone may possess an addiction potential similar to or greater than MDMA, yet patterns of self-administration and effects on brain reward function suggest that this drug may have a lower potential for abuse and compulsive use than prototypical psychostimulants.
Human Pharmacology of Mephedrone in Comparison with MDMA
Mephedrone elicited stimulant-like effects, euphoria, and well-being, and induced mild changes in perceptions with similar ratings to those observed after MDMA administration although effects peaked earlier and were shorter in duration.
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.
The lack of linearity of MDMA pharmacokinetics (in a window of doses compatible with its recreational use) is a more general phenomenon as it concerns the whole population independent of their CYP2D6 genotype.
The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety
Designer drugs on the internet: a phenomenon out-of-control? the emergence of hallucinogenic drug Bromo-Dragonfly.
It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge and better international collaboration levels may be needed to tackle this novel and fast growing phenomenon.
Amphetamine enantiomer excretion profile following administration of Adderall.
Results are the first to describe the excretion of amphetamine following administration of Adderall, a 3:1 mixture of d- and l-enantiomers of Amphetamine salts.